Mary Reumuth's Securities Transactions in KALA BIO, Inc.

Mary Reumuth, an officer of KALA BIO, Inc., has filed a Form 144 notice indicating her intention to sell securities. The filing details include the sale of 967 units of common stock, with an aggregate market value of $793.21. The securities were acquired through exercised shares and an employee stock purchase plan. Additionally, Reumuth sold 32,230 units of common stock in the past three months, generating gross proceeds of $26,728.34. The transactions are scheduled to occur around October 23, 2025, and involve Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.